Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
Clinical trial NCT03463265 · COMPLETED
Trial details
- NCT number
- NCT03463265
- Sponsor
- Aadi Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2022-08-26
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.